Maravai LifeSciences Holdings, Inc.
US ˙ NasdaqGS ˙ US56600D1072

SecurityMRVI / Maravai LifeSciences Holdings, Inc.
InstitutionEthic Inc.
Latest Disclosed Ownership11,937 shares
Latest Disclosed Value $ 33,782
Ethic Inc. reports 6.47% decrease in ownership of MRVI / Maravai LifeSciences Holdings, Inc.

On April 27, 2026 - Ethic Inc. filed a 13F-HR form disclosing ownership of 11,937 shares of Maravai LifeSciences Holdings, Inc. (US:MRVI) valued at $33,782 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 12,763 shares of Maravai LifeSciences Holdings, Inc.. This represents a change in shares of -6.47% during the quarter. The current value of the position is $59,566 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F MARAVAI LIFESCIENCES HOLDINGS COM CL A 56600D107 11,937 -826 -6.47 34 -19.51 0.0005
2026-02-03 2025-12-31 13F MARAVAI LIFESCIENCES HOLDINGS COM CL A 56600D107 12,763 -4,188 -24.71 41 -14.58 0.0006
2025-10-17 2025-09-30 13F MARAVAI LIFESCIENCES HOLDINGS COM 56600D107 16,951 6,540 62.82 49 92.00 0.0008
2025-07-30 2025-06-30 13F MARAVAI LIFESCIENCES HOLDINGS COM 56600D107 10,411 10,411 26 0.0005
2025-02-14 2024-12-31 13F MARAVAI LIFESCIENCES HLDGS I COM CL A 56600D107 0 -13,896 -100.00 0 -100.00
2024-11-13 2024-09-30 13F MARAVAI LIFESCIENCES HLDGS I COM CL A 56600D107 13,896 3,451 33.04 120 62.16 0.0030
2024-08-13 2024-06-30 13F MARAVAI LIFESCIENCES HLDGS I COM CL A 56600D107 10,445 -3,451 -24.83 75 -38.33 0.0018
2024-05-13 2024-03-31 13F MARAVAI LIFESCIENCES HLDGS I COM CL A 56600D107 13,896 2,417 21.06 120 60.00 0.0030
2024-02-14 2023-12-31 13F MARAVAI LIFESCIENCES HLDGS I COM CL A 56600D107 11,479 11,479 75 0.0022
2023-08-14 2023-06-30 13F MARAVAI LIFESCIENCES HLDGS I COM CL A 56600D107 0 -12,623 -100.00 0 -100.00
2023-05-12 2023-03-31 13F MARAVAI LIFESCIENCES HLDGS I COM CL A 56600D107 12,623 2,434 23.89 177 21.38 0.0072
2023-02-14 2022-12-31 13F MARAVAI LIFESCIENCES HLDGS I COM CL A 56600D107 10,189 10,189 146 0.0079
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.